APM

Aptorum Group Limited Class A Ordinary Shares (APM)

About Aptorum Group Limited Class A Ordinary Shares (APM)

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.

Details

Daily high
$1.27
Daily low
$1.18
Price at open
$1.23
52 Week High
$17.49
52 Week Low
$0.46
Market cap
8.5M
Dividend yield
0.00%
Volume
46,550
Avg. volume
184,497
P/E ratio
63.64

Aptorum Group Limited Class A Ordinary Shares News

Details

Daily high
$1.27
Daily low
$1.18
Price at open
$1.23
52 Week High
$17.49
52 Week Low
$0.46
Market cap
8.5M
Dividend yield
0.00%
Volume
46,550
Avg. volume
184,497
P/E ratio
63.64